These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 9218627

  • 1. Induction of antigen-specific tolerance for the treatment of ongoing, relapsing autoimmune encephalomyelitis: a comparison between oral and peripheral tolerance.
    Kennedy KJ, Smith WS, Miller SD, Karpus WJ.
    J Immunol; 1997 Jul 15; 159(2):1036-44. PubMed ID: 9218627
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of relapsing experimental autoimmune encephalomyelitis in SJL mice by feeding the immunodominant PLP139-151 peptide.
    Karpus WJ, Kennedy KJ, Smith WS, Miller SD.
    J Neurosci Res; 1996 Aug 15; 45(4):410-23. PubMed ID: 8872901
    [Abstract] [Full Text] [Related]

  • 3. Lymphocytes from SJL/J mice immunized with spinal cord respond selectively to a peptide of proteolipid protein and transfer relapsing demyelinating experimental autoimmune encephalomyelitis.
    Whitham RH, Bourdette DN, Hashim GA, Herndon RM, Ilg RC, Vandenbark AA, Offner H.
    J Immunol; 1991 Jan 01; 146(1):101-7. PubMed ID: 1701788
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of murine relapsing experimental autoimmune encephalomyelitis by immune tolerance to proteolipid protein and its encephalitogenic peptides.
    Kennedy MK, Tan LJ, Dal Canto MC, Tuohy VK, Lu ZJ, Trotter JL, Miller SD.
    J Immunol; 1990 Feb 01; 144(3):909-15. PubMed ID: 1688591
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin antigens: IV. Suppression of chronic relapsing disease in the Lewis rat and strain 13 guinea pig.
    Brod SA, al-Sabbagh A, Sobel RA, Hafler DA, Weiner HL.
    Ann Neurol; 1991 Jun 01; 29(6):615-22. PubMed ID: 1716432
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Relapsing and remitting experimental allergic encephalomyelitis: a focused response to the encephalitogenic peptide rather than epitope spread.
    Takács K, Chandler P, Altmann DM.
    Eur J Immunol; 1997 Nov 01; 27(11):2927-34. PubMed ID: 9394820
    [Abstract] [Full Text] [Related]

  • 11. Regulation of the effector stages of experimental autoimmune encephalomyelitis via neuroantigen-specific tolerance induction. II. Fine specificity of effector T cell inhibition.
    Tan LJ, Kennedy MK, Miller SD.
    J Immunol; 1992 May 01; 148(9):2748-55. PubMed ID: 1374098
    [Abstract] [Full Text] [Related]

  • 12. Pathologic role and temporal appearance of newly emerging autoepitopes in relapsing experimental autoimmune encephalomyelitis.
    Vanderlugt CL, Neville KL, Nikcevich KM, Eagar TN, Bluestone JA, Miller SD.
    J Immunol; 2000 Jan 15; 164(2):670-8. PubMed ID: 10623809
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Mannosylated self-peptide inhibits the development of experimental autoimmune encephalomyelitis via expansion of nonencephalitogenic T cells.
    Kel JM, Slütter B, Drijfhout JW, Koning F, Nagelkerken L.
    J Leukoc Biol; 2008 Jul 15; 84(1):182-90. PubMed ID: 18424662
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Specific immune regulation of chronic-relapsing experimental allergic encephalomyelitis in mice.
    Kennedy MK, Dal Canto MC, Trotter JL, Miller SD.
    J Immunol; 1988 Nov 01; 141(9):2986-93. PubMed ID: 2459237
    [Abstract] [Full Text] [Related]

  • 19. Treatment of experimental encephalomyelitis with a novel chimeric fusion protein of myelin basic protein and proteolipid protein.
    Elliott EA, McFarland HI, Nye SH, Cofiell R, Wilson TM, Wilkins JA, Squinto SP, Matis LA, Mueller JP.
    J Clin Invest; 1996 Oct 01; 98(7):1602-12. PubMed ID: 8833909
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.